Standards; Pharmaceutical/API Drug Impurities/Metabolites; JWH Compounds/Synthetic Cannabinoids;
应用:
HU 433 is a a promising therapeutic target for various forms of tissue injury and inflammatory diseases. It is an enantiomer of HU 308, a cannabinoid CB2 receptor.